목적: Benign tumors of the external nose present challenges in balancing optimal tumor excision with preservation of nasal function and aesthetics. Understanding the various histologic diagnoses and surgical strategies is critical for effective management. Our objective was to delineate histologic diagnoses, surgical strategies and outcomes associated with benign mass lesions of the external nose. 방법:A single-center retrospective cohort study conducted from November 2006 to March 2023 at Asan Medical Center, Seoul, Korea. A single surgeon performed the surgeries for complete or partial tumor removal for cosmetic enhancement. The analysis included 24 patients with benign tumors of the external nose were analyzed. The pathologic type of the benign tumors arising from the external nose was identified. Surgical interventions for tumor excision included complete or partial removal via open rhinoplasty or direct tumor excision with an incision on the nasal dorsum or ala, accompanied by partial excision of the overlying skin. Postoperative outcomes were assessed, focusing on recurrence. 결과:The study included24 patients with a mean age of 32.7 ± 19.2 (range, 3 months-65 years) years at diagnosis. The nasal dorsum was the predominant site of tumor manifestation (n = 11). Among the 11 histologic tumor types, hemangioma was most common (n = 8). Patients with hemangiomas were more likely to be female (p = 0.034) and managed with just an open rhinoplasty approach (p = 0.048). Seventeen patients (70.8%) were treated with the open rhinoplasty approach. Recurrence was observed in 4 patients (16.7%) at an average interval of 3.2± 2.9 years following surgery. Cosmetic considerations prompted intentional partial tumor removal in 4 cases. 결론:Benign tumors of the external nose exhibit diverse pathology. Preservation of nasal aesthetics is crucial, favoring an open rhinoplasty approach. Partial tumor removal may be considered in extensive cases with skin involvement. The results of this study highlight the need for tailored surgical strategies in managing these rare tumors.